Last updated: 11/07/2018 15:23:26

A randomized, parallel group, open study to evaluate the impact of additional guidance provided by health care professionals on treatment compliance among asthmatic patients with persistent asthma (ADERE)

GSK study ID
ADERE ADULT
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Overview
Eligibility
Locations
Study documents
Results summary
Plain language summaries
Additional information

Trial overview

Official title: A randomized, parallel group, open study to evaluate the impact of additional guidance provided by health care professionals on treatment compliance among asthmatic patients with persistent asthma (ADERE)
Trial description: A randomized, parallel group, open study to evaluate the impact of additional guidance provided by health care professionals on treatment compliance among asthmatic patients with persistent asthma (ADERE)
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Not applicable
Secondary outcomes:
Not applicable
Interventions:
Not applicable
Enrollment:
Not applicable
Primary completion date:
Not applicable
Observational study model:
Not applicable
Time perspective:
Not applicable
Clinical publications:
1) Blanco DC, Chatkin J M, Tonietto R, Scaglia N, Fristcher CC . [A39][Poster: G7] Assessment of persistent asthma treatment compliance in Brazil. In: American Thoracic Society - 100th International Conference, 2005, San Diego, USA. Proceedings of the American Thoracic Society, 2005. v. 2. p. A113.
2) Blanco D C, Chatkin JM, Tonietto R, Scaglia N, Fritscher CC. [A16] Impact of a low-cost and simple intervention to increase asthma treatment compliance. In: American Thoracic Society - 100th International Conference, 2005, San Diego, USA. Proceedings of the American Thoracic Society, 2005. v. 2. p. A22.
3) Chatkin JM, Cavaletblanco D, Tonietto R, Scaglia, N, Fritscher, Cesar C. Adesão ao tratamento de manutençao de asma no Brasil. In: IV Congreso de la Associacion Latinoamericana del Torax, 2004, Buenos Aires. Archivos de Bronchoneumologia. Barcelona, Espanha : Ediciones Doyma SL, 2004. v. 40. p. 84.
4) Chatkin JM, Cavaletblanco D, Scaglia N, Tonietto R . Impacto de telefonemas quinzenais na adesão ao tratamento de manutençao de asma. In: IV Congreso de la Associacion latinoamericana del Torax, 2004, Buenos Aires. Archivos de Bronchoneumologia. Barcelona, Espanha : Ediciones Doyma SL, 2004. v. 40. p. 85.
5) Blanco DC, Chatkin J M, Scaglia NC, Tonietto R, Wagner MB, Fritscher CC. Tratamento da Manutenção da Asma: Como é a Adesão no Brasil?. In: XXXII Congresso Brasileiro de Pneumologia e Tisiologia e do III Congresso Luso-Brasileiro de Pneumologia, 2004, Salvador - Bahia. Jornal Brasileiro de Pneumologia. São Paulo - SP : Redprint Editora, 2004. v. 30. p. 22.
6) Blanco DC, Fritscher CC, Scaglia NC, Tonietto R, Wagner MB, Chatkin JM . Aumento na Adesão ao Tratamento da Asma por Intervenção de Baixo Custo. In: XXXII Congresso Brasileiro de Pneumologia e Tisiologia e do III Congresso Luso-Brasileiro de Pneumologia, 2004, Salvador - Bahia. Jornal Brasileiro de Pneumologia. São Paulo - SP : Redprint Editora, 2004. v. 30. p. 23.
Medical condition
Asthma
Product
fluticasone propionate/salmeterol
Collaborators
Not applicable
Study date(s)
November 2003 to March 2004
Type
Not applicable
Phase
4

Participation criteria

Sex
Not applicable
Age
Not applicable
Accepts healthy volunteers
Not applicable

Trial location(s)

This study does not involve prospective enrollment of participants.

Study documents

Scientific result summary
Available language(s): English

If you wish to request for full study report, please contact - [email protected]

Results overview

Not applicable

Recruitment status
Study complete
Actual primary completion date
Not applicable
Actual study completion date
2004-31-03

Plain language summaries

Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.

Additional information about the trial

Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website